SoundHound AI stock jumps 7% ahead of Monday as CES demos and TomTom tie-up keep SOUN in focus

SoundHound AI stock jumps 7% ahead of Monday as CES demos and TomTom tie-up keep SOUN in focus

New York, Jan 11, 2026, 07:23 (EST) — The market has closed.

  • SoundHound AI wrapped up Friday with a 6.62% gain, closing at $11.75 after fluctuating between $11.29 and $12.31 during the session. (AAII)
  • At CES 2026, the company showcased its “agentic” voice commerce capabilities, highlighting features like OpenTable reservations and Parkopedia parking payments. (SoundHound AI)
  • SoundHound hasn’t announced its next earnings date yet; MarketBeat puts the estimate at Feb. 26. (MarketBeat)

Shares of SoundHound AI, Inc surged 6.7% on Friday, closing at $11.75 after roughly 39.3 million shares changed hands. The rally faces its true test once U.S. markets open Monday.

SoundHound’s market cap hovers around $4.9 billion, placing it in a corner of the AI sector known for rapid capital shifts. This volatility leaves the stock highly reactive to news—and just as vulnerable when it goes quiet. (Yahoo Finance)

Why it matters now: CES 2026 ended after four days in Las Vegas, and this week marks the crunch time for buyers deciding which demos move to actual deployments. Organizers reported over 148,000 attendees. (CES)

SoundHound used CES to highlight what it calls “agentic” voice commerce — software that doesn’t just answer questions but actually takes action, like placing orders. “SoundHound is showcasing a whole ecosystem of AI agents that perform tasks and transactions,” CEO Keyvan Mohajer said in a statement. (GlobeNewswire)

TomTom announced a new partnership with SoundHound this week to roll out a combined in-car voice and navigation assistant. The duo is promoting a multi-agent system designed to tackle complex routing tasks and EV charging searches using natural language. “Our goal is to make driving experiences more intuitive and truly voice-enabled,” said SoundHound automotive exec Matt Anderson. (GlobeNewswire)

Signs of caution emerged as DA Davidson cut its price target for SoundHound, according to a Reuters headline reported on TradingView. For context, a price target reflects where an analyst expects a stock to land within the next year. (TradingView)

The wider market lent support as well. U.S. stocks finished Friday on a high note, with the Dow and S&P 500 hitting record closes. This followed a December jobs report that revealed slower hiring alongside a drop in the unemployment rate, according to Investopedia. (Investopedia)

SoundHound still needs to prove that the features it debuts on the CES stage actually lead to signed deals—and that its new AI tools won’t just drive up costs. The market’s packed, with major tech firms and auto software suppliers all rolling out their own voice assistants and in-cabin “agents.”

Positioning might fuel the volatility. MarketBeat data put short interest near 30.6% of the public float as of Dec. 15; heavy short selling tends to magnify moves when volume jumps. (MarketBeat)

SoundHound’s investor page shows no scheduled events, so traders are left waiting for customer news, partner updates, or filings after CES. Monday’s open should reveal if Friday’s surge was just a brief liquidity squeeze or the start of a more lasting move. (SoundHound AI)

Earnings are the next key event to watch. According to Nasdaq’s earnings page, SoundHound is expected to report on Feb. 26. Any news on revenue timing from its automotive programs or voice-commerce partners could move the stock as February closes out. (Nasdaq)

Stock Market Today

  • Profound Medical: Top TSX Growth Stock Poised for Rapid Expansion, Q3 Revenues Surge 87%
    February 1, 2026, 9:22 PM EST. Profound Medical (TSX:PRN), a Canadian medical device firm specializing in MRI-guided ultrasound therapies, is highlighted as the sole TSX growth stock to hold for the next three years. The company reported an 87% revenue increase in Q3 to $5.3 million, driven by expanded installations of its flagship TULSA-PRO prostate cancer treatment system. Offering incision-free, MRI-guided ablation technology, Profound's procedures have gained Medicare approval with rising insurance reimbursements. Despite a net loss of $8 million, the company improved gross margins to 74.3% and ended Q3 with $25 million cash, supporting near-term liquidity. With 70 systems installed and 93 in advanced sales stages, Profound aims for 75 installations by year-end, making it a notable small-cap growth stock in healthcare on the TSX.
AGNC stock rises on Trump’s $200B mortgage-bond push — what to watch before Monday
Previous Story

AGNC stock rises on Trump’s $200B mortgage-bond push — what to watch before Monday

IREN stock on watch Monday after Bernstein calls it a “top AI pick” as crypto traders eye CPI
Next Story

IREN stock on watch Monday after Bernstein calls it a “top AI pick” as crypto traders eye CPI

Go toTop